GEN | News Highlights: Regeneron and Sanofi-Aventis Report Positive Phase III mCRC Trial Data Posted on 27 April 2011 by kfshea Posted in Clinical Trials GEN | News Highlights: Regeneron and Sanofi-Aventis Report Positive Phase III mCRC Trial Data.